Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Progenics Pharmaceuticals Inc (PGNX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Progenics Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 835887.
Total stock buying since 2014: $11,339,189.
Total stock sales since 2014: $9,507,446.
Total stock option exercises since 2014: $593,157.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 862,117 | $3,863,022 | 0 | $0 | 72,000 | $378,979 |
| 2017 | 0 | $0 | 953,900 | $9,227,413 | 0 | $0 |
| 2015 | 0 | $0 | 14,000 | $94,882 | 14,000 | $71,529 |
| 2014 | 1,625,436 | $7,476,167 | 27,000 | $185,151 | 27,000 | $142,649 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-09 | 658,061 | $2,984,404 | 0 | $0 | 0 | $0 |
| 2019-08 | 204,056 | $878,618 | 0 | $0 | 0 | $0 |
| 2019-07 | 0 | $0 | 0 | $0 | 22,000 | $111,979 |
| 2019-06 | 0 | $0 | 0 | $0 | 50,000 | $267,000 |
| 2017-02 | 0 | $0 | 953,900 | $9,227,413 | 0 | $0 |
| 2015-06 | 0 | $0 | 2,000 | $13,660 | 2,000 | $10,660 |
| 2015-03 | 0 | $0 | 10,000 | $67,110 | 10,000 | $50,209 |
| 2015-01 | 0 | $0 | 2,000 | $14,112 | 2,000 | $10,660 |
| 2014-12 | 0 | $0 | 3,000 | $21,201 | 3,000 | $16,049 |
| 2014-11 | 0 | $0 | 24,000 | $163,950 | 24,000 | $126,600 |
| 2014-07 | 1,625,436 | $7,476,167 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-09 | Melkonian Ryan | Buy | 21,480 | 4.94 | 106,089 |
| 2019-09-09 | Venkataraman Balaji | Buy | 72,023 | 5.00 | 359,754 |
| 2019-09-05 | Melkonian Ryan | Buy | 43,520 | 4.62 | 201,105 |
| 2019-09-04 | Venkataraman Balaji | Buy | 243,614 | 4.51 | 1,098,455 |
| 2019-09-03 | Venkataraman Balaji | Buy | 277,424 | 4.39 | 1,219,001 |
| 2019-08-26 | Venkataraman Balaji | Buy | 73,230 | 4.30 | 314,889 |
| 2019-08-23 | Venkataraman Balaji | Buy | 130,826 | 4.31 | 563,729 |
| 2019-07-03 | Campbell Bradley L | Option Ex | 12,000 | 4.89 | 58,679 |
| 2019-07-01 | Scheinberg David A | Option Ex | 10,000 | 5.33 | 53,300 |
| 2019-06-26 | Crowley Peter J | Option Ex | 50,000 | 5.34 | 267,000 |
| 2017-02-15 | Kotler Kevin | Sale | 150,000 | 9.55 | 1,432,500 |
| 2017-02-14 | Kotler Kevin | Sale | 352,600 | 9.70 | 3,418,457 |
| 2017-02-13 | Kotler Kevin | Sale | 100,000 | 9.70 | 969,999 |
| 2017-02-09 | Broadfin Capital, Llc | Sale | 201,300 | 9.70 | 1,952,207 |
| 2017-02-07 | Broadfin Capital, Llc | Sale | 150,000 | 9.70 | 1,454,250 |
| 2015-06-11 | Israel Robert J (Executive Vice President, Medi) | Sale | 2,000 | 6.83 | 13,660 |
| 2015-06-11 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 2,000 | 5.33 | 10,660 |
| 2015-03-13 | Israel Robert J (Executive Vice President, Medi) | Sale | 3,000 | 7.00 | 21,000 |
| 2015-03-13 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 3,000 | 5.35 | 16,049 |
| 2015-03-11 | Israel Robert J (Executive Vice President, Medi) | Sale | 2,000 | 6.83 | 13,660 |
| 2015-03-11 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 2,000 | 5.33 | 10,660 |
| 2015-03-03 | Israel Robert J (Executive Vice President, Medi) | Sale | 5,000 | 6.49 | 32,450 |
| 2015-03-03 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 5,000 | 4.70 | 23,500 |
| 2015-01-12 | Israel Robert J (Executive Vice President, Medi) | Sale | 2,000 | 7.06 | 14,112 |
| 2015-01-12 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 2,000 | 5.33 | 10,660 |
| 2014-12-11 | Israel Robert J (Executive Vice President, Medi) | Sale | 3,000 | 7.07 | 21,201 |
| 2014-12-11 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 3,000 | 5.35 | 16,049 |
| 2014-11-21 | Israel Robert J (Executive Vice President, Medi) | Sale | 9,000 | 7.00 | 63,000 |
| 2014-11-21 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 9,000 | 5.35 | 48,150 |
| 2014-11-13 | Israel Robert J (Executive Vice President, Medi) | Sale | 10,000 | 6.83 | 68,300 |
| 2014-11-13 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 10,000 | 5.33 | 53,300 |
| 2014-11-11 | Israel Robert J (Executive Vice President, Medi) | Sale | 5,000 | 6.53 | 32,650 |
| 2014-11-11 | Israel Robert J (Executive Vice President, Medi) | Option Ex | 5,000 | 5.03 | 25,150 |
| 2014-07-21 | Kotler Kevin | Buy | 388,659 | 4.73 | 1,838,357 |
| 2014-07-18 | Kotler Kevin | Buy | 388,200 | 4.73 | 1,836,186 |
| 2014-07-17 | Kotler Kevin | Buy | 436,884 | 4.48 | 1,957,240 |
| 2014-07-16 | Kotler Kevin | Buy | 411,693 | 4.48 | 1,844,384 |
Insider trading activities including stock purchases, stock sales, and option exercises of PGNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Progenics Pharmaceuticals Inc (symbol PGNX, CIK number 835887) see the Securities and Exchange Commission (SEC) website.